<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Hum Mol Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Hum. Mol. Genet</journal-id>
<journal-id journal-id-type="publisher-id">hmg</journal-id>
<journal-title-group>
<journal-title>Human Molecular Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">0964-6906</issn>
<issn pub-type="epub">1460-2083</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28911200</article-id>
<article-id pub-id-type="pmc">5886049</article-id>
<article-id pub-id-type="doi">10.1093/hmg/ddx239</article-id>
<article-id pub-id-type="publisher-id">ddx239</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Homozygous <italic>EEF1A2</italic> mutation causes dilated cardiomyopathy, failure to thrive, global developmental delay, epilepsy and early death</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Cao</surname>
<given-names>Siqi</given-names>
</name>
<xref ref-type="aff" rid="ddx239-aff1">1</xref>
<xref ref-type="aff" rid="ddx239-aff2">2</xref>
<xref ref-type="aff" rid="ddx239-aff3">3</xref>
<author-comment content-type="other">
<p>
<sup>†</sup>The authors wish it to be known that, in their opinion, the first 2 authors should be regarded as joint First Authors.</p>
</author-comment>
<xref ref-type="author-notes" rid="ddx239-FM1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Smith</surname>
<given-names>Laura L.</given-names>
</name>
<xref ref-type="aff" rid="ddx239-aff2">2</xref>
<author-comment content-type="other">
<p>
<sup>†</sup>The authors wish it to be known that, in their opinion, the first 2 authors should be regarded as joint First Authors.</p>
</author-comment>
<xref ref-type="author-notes" rid="ddx239-FM1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Padilla-Lopez</surname>
<given-names>Sergio R.</given-names>
</name>
<xref ref-type="aff" rid="ddx239-aff5">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Guida</surname>
<given-names>Brandon S.</given-names>
</name>
<xref ref-type="aff" rid="ddx239-aff5">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Blume</surname>
<given-names>Elizabeth</given-names>
</name>
<xref ref-type="aff" rid="ddx239-aff4">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shi</surname>
<given-names>Jiahai</given-names>
</name>
<xref ref-type="aff" rid="ddx239-aff6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Morton</surname>
<given-names>Sarah U.</given-names>
</name>
<xref ref-type="aff" rid="ddx239-aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Brownstein</surname>
<given-names>Catherine A.</given-names>
</name>
<xref ref-type="aff" rid="ddx239-aff2">2</xref>
<xref ref-type="aff" rid="ddx239-aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Beggs</surname>
<given-names>Alan H.</given-names>
</name>
<xref ref-type="aff" rid="ddx239-aff2">2</xref>
<xref ref-type="aff" rid="ddx239-aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kruer</surname>
<given-names>Michael C.</given-names>
</name>
<xref ref-type="aff" rid="ddx239-aff5">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Agrawal</surname>
<given-names>Pankaj B.</given-names>
</name>
<xref ref-type="aff" rid="ddx239-aff1">1</xref>
<xref ref-type="aff" rid="ddx239-aff2">2</xref>
<xref ref-type="aff" rid="ddx239-aff3">3</xref>
<xref ref-type="corresp" rid="ddx239-cor1"></xref>
<!--<email>pagrawal@enders.tch.harvard.edu</email>-->
</contrib>
</contrib-group>
<aff id="ddx239-aff1">
<label>1</label>Division of Newborn Medicine</aff>
<aff id="ddx239-aff2">
<label>2</label>Division of Genetics and Genomics</aff>
<aff id="ddx239-aff3">
<label>3</label>The Manton Center for Orphan Disease Research</aff>
<aff id="ddx239-aff4">
<label>5</label>Department of Cardiology, Boston Children's Hospital and Harvard Medical School, Boston, MA 02115, USA</aff>
<aff id="ddx239-aff5">
<label>4</label>Department of Child Health, Barrow Neurological Institute, Phoenix Children's Hospital, University of Arizona College of Medicine, Phoenix, AZ 85013, USA</aff>
<aff id="ddx239-aff6">
<label>6</label>Department of Biomedical Sciences, City University of Hong Kong, Hong Kong SAR</aff>
<author-notes>
<fn id="ddx239-FM1">
<label>†</label>
<p>The authors wish it to be known that, in their opinion, the first 2 authors should be regarded as joint First Authors.</p>
</fn>
<corresp id="ddx239-cor1"><label>*</label>To whom correspondence should be addressed at: Divisions of Newborn Medicine and Genetics &amp; Genomics, Boston Children’s Hospital, 300 Longwood Ave CLSB 15030, Boston, MA 02115, USA. Tel: +617 9192153; Fax: +617 7300253; Email: <email>pagrawal@enders.tch.harvard.edu</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>15</day>
<month>9</month>
<year>2017</year>
</pub-date>
<pub-date iso-8601-date="2017-06-26" pub-type="epub">
<day>26</day>
<month>6</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>15</day>
<month>9</month>
<year>2018</year>
</pub-date>
<!-- PMC Release delay is 12 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>26</volume>
<issue>18</issue>
<fpage>3545</fpage>
<lpage>3552</lpage>
<history>
<date date-type="received">
<day>20</day>
<month>4</month>
<year>2017</year>
</date>
<date date-type="rev-recd">
<day>9</day>
<month>6</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>20</day>
<month>6</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com</copyright-statement>
<copyright-year>2017</copyright-year>
</permissions>
<self-uri xlink:href="ddx239.pdf"></self-uri>
<abstract>
<title>Abstract</title>
<p>Eukaryotic elongation factor 1A (EEF1A), is encoded by two distinct isoforms, <italic>EEF1A1</italic> and <italic>EEF1A2</italic>; whereas <italic>EEF1A1</italic> is expressed almost ubiquitously, <italic>EEF1A2</italic> expression is limited such that it is only detectable in skeletal muscle, heart, brain and spinal cord. Currently, the role of EEF1A2 in normal cardiac development and function is unclear. There have been several reports linking <italic>de novo</italic> dominant <italic>EEF1A2</italic> mutations to neurological issues in humans. We report a pair of siblings carrying a homozygous missense mutation p.P333L in <italic>EEF1A2</italic> who exhibited global developmental delay, failure to thrive, dilated cardiomyopathy and epilepsy, ultimately leading to death in early childhood. A third sibling also died of a similar presentation, but DNA was unavailable to confirm the mutation. Functional genomic analysis was performed in <italic>S. cerevisiae</italic> and zebrafish. In <italic>S. cerevisiae</italic>, there was no evidence for a dominant-negative effect. Previously identified putative <italic>de novo</italic> mutations failed to complement yeast strains lacking the <italic>EEF1A</italic> ortholog showing a major growth defect. In contrast, the introduction of the mutation seen in our family led to a milder growth defect. To evaluate its function in zebrafish, we knocked down <italic>eef1a2</italic> expression using translation blocking and splice-site interfering morpholinos. EEF1A2-deficient zebrafish had skeletal muscle weakness, cardiac failure and small heads. Human <italic>EEF1A2</italic> wild-type mRNA successfully rescued the morphant phenotype, but mutant RNA did not. Overall, EEF1A2 appears to be critical for normal heart function in humans, and its deficiency results in clinical abnormalities in neurologic function as well as in skeletal and cardiac muscle defects.</p>
</abstract>
<funding-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">NIAMS</named-content>
<named-content content-type="funder-identifier">10.13039/100000069</named-content>
</funding-source>
<award-id>HD077671 (PBA and AHB), and R01 HD075802 (AHB) from NICHD, and K08 NS083739 (MCK)</award-id>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">National Institutes of Health</named-content>
<named-content content-type="funder-identifier">10.13039/100000002</named-content>
</funding-source>
<award-id>U54 HD090255</award-id>
</award-group>
</funding-group>
<counts>
<page-count count="8"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>